Related Experiment Videos
Aromatase inhibitors for breast cancer--further progress
European Journal of Cancer (Oxford, England : 1990)
|June 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification scheme.
European journal of cancer (Oxford, England : 1990)·2003
7. Management of advanced breast cancer.
International journal of clinical practice·2002
Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2001
Risk of complications from bone metastases in breast cancer. implications for management.
European journal of cancer (Oxford, England : 1990)·2000
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer.
British journal of cancer·1999
Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
European journal of cancer (Oxford, England : 1990)·2026
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.
European journal of cancer (Oxford, England : 1990)·2026
Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.
European journal of cancer (Oxford, England : 1990)·2026
Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
European journal of cancer (Oxford, England : 1990)·2026
Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.
European journal of cancer (Oxford, England : 1990)·2026
Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.
European journal of cancer (Oxford, England : 1990)·2026